197 related articles for article (PubMed ID: 12781698)
21. Staphylococcal enterotoxin B activates purified NK cells to secrete IFN-gamma but requires T lymphocytes to augment NK cytotoxicity.
D'Orazio JA; Burke GW; Stein-Streilein J
J Immunol; 1995 Feb; 154(3):1014-23. PubMed ID: 7529788
[TBL] [Abstract][Full Text] [Related]
22. Use of quantitative flow cytometry to measure ex vivo immunostimulant activity of echinacea: the case for polysaccharides.
Pillai S; Pillai C; Mitscher LA; Cooper R
J Altern Complement Med; 2007; 13(6):625-34. PubMed ID: 17718645
[TBL] [Abstract][Full Text] [Related]
23. G-CSF-mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotypically novel monocyte.
Sconocchia G; Fujiwara H; Rezvani K; Keyvanfar K; El Ouriaghli F; Grube M; Melenhorst J; Hensel N; Barrett AJ
J Leukoc Biol; 2004 Dec; 76(6):1214-9. PubMed ID: 15345723
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of Fc gamma receptor IIIA alpha (CD16-II) on natural killer cells induced by anti-CD16 mAb is independent of protein tyrosine kinases and protein kinase C.
Borrego F; Lopez-Beltran A; Peña J; Solana R
Cell Immunol; 1994 Oct; 158(1):208-17. PubMed ID: 8087866
[TBL] [Abstract][Full Text] [Related]
25. Natural killer cell lytic activity and CD56(dim) and CD56(bright) cell distributions during and after intensive training.
Suzui M; Kawai T; Kimura H; Takeda K; Yagita H; Okumura K; Shek PN; Shephard RJ
J Appl Physiol (1985); 2004 Jun; 96(6):2167-73. PubMed ID: 14752119
[TBL] [Abstract][Full Text] [Related]
26. CD16 cross-linking induces increased expression of CD56 and production of IL-12 in peripheral NK cells.
Márquez ME; Millet C; Stekman H; Conesa A; Deglesne PA; Toro F; Sanctis JD; Blanca I
Cell Immunol; 2010; 264(1):86-92. PubMed ID: 20553754
[TBL] [Abstract][Full Text] [Related]
27. In vitro responsiveness to interleukins and theophylline of CD16+, CD56- natural killer cells in a patient with chronic granular lymphocyte disorder.
Bayle C; Vitté-Mony I; Lang P; Pico J; Hercend T; Bertoglio J
Leukemia; 1992 May; 6(5):470-6. PubMed ID: 1375700
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic study of natural killer cell subsets in ankylosing spondylitis patients.
Mousavi T; Poormoghim H; Moradi M; Tajik N; Shahsavar F; Soofi M
Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):193-8. PubMed ID: 20404389
[TBL] [Abstract][Full Text] [Related]
29. The correlation between the percent of CD3- CD56+ cells and NK precursor function.
Gharehbaghian A; Donaldson C; Newman J; Bannister G; Bradley BA
Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):167-75. PubMed ID: 17237569
[TBL] [Abstract][Full Text] [Related]
30. Natural killer cell frequency and function in patients with monoclonal gammopathies.
Famularo G; D'Ambrosio A; Quintieri F; Di Giovanni S; Parzanese I; Pizzuto F; Giacomelli R; Pugliese O; Tonietti G
J Clin Lab Immunol; 1992; 37(3):99-109. PubMed ID: 1285130
[TBL] [Abstract][Full Text] [Related]
31. Immunophenotype of peripheral T lymphocytes, NK cells and expression of CD69 activation marker in patients with recurrent spontaneous abortions, during the mid-luteal phase.
Prado-Drayer A; Teppa J; Sánchez P; Camejo MI
Am J Reprod Immunol; 2008 Jul; 60(1):66-74. PubMed ID: 18593439
[TBL] [Abstract][Full Text] [Related]
32. Telomere length in human natural killer cell subsets.
Ouyang Q; Baerlocher G; Vulto I; Lansdorp PM
Ann N Y Acad Sci; 2007 Jun; 1106():240-52. PubMed ID: 17303822
[TBL] [Abstract][Full Text] [Related]
33. Optimized quantification of lymphocyte subsets by use of CD7 and CD33.
Hauser A; Schrattbauer K; Najdanovic D; Schlossnickel R; Koch A; Hejtman M; Krugluger W
Cytometry A; 2013 Mar; 83(3):316-23. PubMed ID: 23315982
[TBL] [Abstract][Full Text] [Related]
34. Immunomodulation by SanPharma fungal metabolic products.
Jensen GS; Hart AN
J Altern Complement Med; 2006 May; 12(4):409-16. PubMed ID: 16722792
[TBL] [Abstract][Full Text] [Related]
35. The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase.
Bottino C; Vitale M; Olcese L; Sivori S; Morelli L; Augugliaro R; Ciccone E; Moretta L; Moretta A
Eur J Immunol; 1994 Oct; 24(10):2527-34. PubMed ID: 7523145
[TBL] [Abstract][Full Text] [Related]
36. A Wilms tumor cell line, HFWT, can greatly stimulate proliferation of CD56+ human natural killer cells and their novel precursors in blood mononuclear cells.
Harada H; Watanabe S; Saijo K; Ishiwata I; Ohno T
Exp Hematol; 2004 Jul; 32(7):614-21. PubMed ID: 15246157
[TBL] [Abstract][Full Text] [Related]
37. Differential oncolytic effect of NK-enriched subsets in long-term interleukin-2 cultures.
Fuchshuber PR; Lotzová E
Lymphokine Cytokine Res; 1992 Oct; 11(5):271-6. PubMed ID: 1281676
[TBL] [Abstract][Full Text] [Related]
38. The effect of interleukin 2 and transforming growth factor-beta 2 (TGF-beta 2) on the proliferation and natural killer activity of decidual CD16- CD56bright natural killer cells.
Saito S; Morii T; Enomoto M; Sakakura S; Nishikawa K; Narita N; Ichijo M
Cell Immunol; 1993 Dec; 152(2):605-13. PubMed ID: 7504983
[TBL] [Abstract][Full Text] [Related]
39. NK cell activity in tuberculosis is associated with impaired CD11a and ICAM-1 expression: a regulatory role of monocytes in NK activation.
Schierloh P; Alemán M; Yokobori N; Alves L; Roldán N; Abbate E; del C Sasiain M; de la Barrera S
Immunology; 2005 Dec; 116(4):541-52. PubMed ID: 16313368
[TBL] [Abstract][Full Text] [Related]
40. Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells.
Baume DM; Robertson MJ; Levine H; Manley TJ; Schow PW; Ritz J
Eur J Immunol; 1992 Jan; 22(1):1-6. PubMed ID: 1370410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
